The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
23 November 2018 | 30 November 2018 Calgary, Alberta | Edmonton, Alberta 08:30 – 08:45 Introductions and Overview of IHE Mr. Dan PalfreyDownload Presentation 08:45 – 09:30 Case Study One Mr. Dan PalfreyDownload Presentation 09:30 – 10:15 Innovation Adoption in Alberta and Canada Dr. Christopher McCabeDownload Presentation 10:15 – 10:30 Break 10:30 – 11:30 Principles of Health Economics…
23 November 2018 | 30 November 2018 Calgary, Alberta | Edmonton, Alberta On November 23rd in Calgary and November 30th in Edmonton, the Institute of Health Economics (IHE) hosted an educational workshop designed to support both early and late stage organizations in developing an understanding of when, where, and how health economics can be used to strengthen product and business…
On November 23rd in Calgary and November 30th in Edmonton, the Institute of Health Economics (IHE) hosted an educational workshop designed to support both early and late stage organizations in developing an understanding of when, where, and how health economics can be used to strengthen product and business planning, and satisfy requirements of purchasers of technology. Participants…
PDF of a PowerPoint presentation by Dan Palfrey, Director, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Christopher McCabe, Executive Director and CEO of the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Christopher McCabe, Executive Director and CEO of the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dan Palfrey, Director, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Andrew Sutton, Senior Health Economist, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Andrew Sutton, Senior Health Economist, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
This report provides a summary of a real-world evidence (RWE) design sprint workshop that took place on October 21, 2018 in Toronto, Ontario. The workshop was developed and delivered as a joint partnership between the Canadian Agency for Drugs and Technologies in Health (CADTH); Canadian Association for Population Therapeutics (CAPT), Health Canada, and the Institute of Health…
| Dat Tran, Robert Welsh, Arto Ohinmaa, Thanh Nguyen, Padma Kaul
Little is known about the resource use and cost burden of acute myocardial infarction (AMI) beyond the index event. We examined resource use and care costs during the first and each subsequent year, among patients with incident AMI.
This environmental scan describes existing initiatives that aim to accelerate the diagnostic phase of cancer care in Alberta, Canada, and internationally. Specifically, it describes their development and implementation, structure and functioning, intended outcomes and effectiveness, costs and cost savings, and enablers and barriers.
Summary Report Defining decision-grade real-world evidence and its role in the Canadian context: A design sprint – Summary report of a workshopDownload Summary Report (English) Définir les données probantes du monde réel utiles à la prise de décisions et leur rôle en contexte canadien: Un sprint de conception Rapport sommaire d’un atelier Téléchargez le rapport sommaire d’un atelier…
21 October 2018 Toronto, Ontario On October 21, 2018, Health Canada, the Canadian Agency for Drugs and Technologies in Health (CADTH), the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) collaborated on Defining Decision-Grade Real-World Evidence and its Role in the Canadian Context: A Design Sprint. Held as a satellite to the…
PDF of a PowerPoint presentation by Dr. Kelvin Chan MD FRCPC MSc (Clin Epi) MSc (Biostats) PhD, Sunnybrook Odette Cancer Centre.
IHE/CAPT Real World Evidence Workshop
PDF of a PowerPoint presentation by Dr. Tammy Clifford, Chief Scientist and Vice-President, Evidence Standards, and Dr. Trevor Richter, Director, Common Drug Review and Optimal Use at CADTH.
IHE/CAPT Real World Evidence Workshop
On October 21, 2018, Health Canada, the Canadian Agency for Drugs and Technologies in Health (CADTH), the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) collaborated on Defining Decision-Grade Real-World Evidence and its Role in the Canadian Context: A Design Sprint. Held as a satellite to the 2018 CAPT conference in Toronto,…
24 September 2018 Calgary, Alberta On September 24th, 2018 the Institute Health Economics (IHE) presented a roundtable at the BIO Alberta AGM and Conference. This Roundtable provided an overview of the IHE's education series for Alberta SMEs and ecosystem partners, and enabled participants to help define the content of the series so it would be most valuable to them. Beginning…
Health Technology Innovation Platform (HTIP) events are designed to support the HTIP initiative, by collaborating with and providing support for small- and medium-sized enterprises (SMEs) as well as multi-national enterprises (MNEs) in the life sciences. These events support the mission of the HTIP to enhance decision-making efficiency and improve value for money for purchasers…
14 September 2018 Edmonton, Alberta The Institute of Health Economics and The Network of Alberta Health Economists were pleased to present "Reflections on Balancing Academic and Policy Work," a mentorship and networking event for early career health economists (7 years or less from completion of PhD studies), with renown Health Economist, Dr. Karl Claxton, Professor of Economics,…
In the development of early stage life sciences technology, it's imperative to understand whether healthcare organizations are likely to purchase your innovation, and consequently provide a return on investment. Healthcare organizations make purchase decisions based upon clinical AND economic (value for money) considerations. Our early stage technology assessment service can help…
Speaker Biographies Keynote Speaker Dr. Catherine CalderwoodChief Medical Officer, Scotland Catherine Calderwood has been the Chief Medical Officer for Scotland since 2015. Catherine qualified from Cambridge and Glasgow Universities and continues to work as an obstetrician at a regular antenatal clinic at the Royal Infirmary of Edinburgh. She is responsible for the Health Promoting…
19 September 2018Edmonton, Alberta Welcome and Greetings WelcomeDr. Lorne TyrrellBoard Chair, IHE Greetings from the ProvinceMr. Justin RiemerAssistant Deputy Minister, Innovation and Strategic Operations Division, Alberta Healthhttps://vimeo.com/album/5450281/video/292002619 Keynote Presentations Realistic Medicine – Lessons from ScotlandDr. Catherine CalderwoodChief Medical Officer,…
19 September 2018Edmonton, Alberta Realistic Medicine - Trailer Realistic Medicine is the 18th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 18th IHE Innovation Forum Keynote Speaker is Dr. Catherine Calderwood, Chief Medical Officer for the Scottish Government.…
Realistic Medicine is the 18th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
Institute of Health Economics – Corporate Reports The Institute of Health Economics (IHE) is a not-for-profit organization funded through grants and commissioned work from public and private sector partners. The IHE is committed to transparency and accountability in the work we conduct. Key corporate reports which are completed and in development are outlined below. Strategic Plan:…
4 – 6 November 2014 Edmonton, Alberta The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS), hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 – 6, 2014. Download Consensus Statement | Télécharger la déclaration de consensus The…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
Past Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. Events hosted or co-hosted by the IHE include the well-regarded Consensus Development Conference Series, which has seen us host international events on Fetal Alcohol Spectrum Disorder…
IHE Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. The IHE hosts various events of different sizes and audiences, on a wide variety of topics. Past events have included Health Policy events, the IHE Innovation Forum series, Roundtables,…
The Institute of Health Economics (IHE) is a unique collaborative arrangement among government, academia, and industry. Established in 1995, the IHE is committed to gathering and disseminating evidence-based findings from health economics, health policy, health technology assessment and comparative effectiveness research to support health policy and practice.
| S.P. Bisch, T. Wells, L. Gramlich, P. Faris, X. Wang, Dat Tran, Thanh Nguyen, S. Glaze, P. Chu, P. Ghatage, J. Nation, V. Capstick, H. Steed, J. Sabourin, G. Nelson
The Institute of Health Economics has contributed to a study published in the Journal Gynecologic Oncology. The study described the effects of Enhanced Recovery After Surgery (ERAS) guideline implementation in gynecologic oncology on length of stay, patient outcomes, and economic impact in Alberta. The study compared pre-and post-guideline implementation outcomes at two centers…
This study originated from discussions on how to translate research findings into conclusions regarding safety and effectiveness in systematic reviews responding to requests from a provincial mechanism for introducing and diffusing publicly funded healthcare technologies. Its objective is to identify prominent and reliable evidence grading systems used in health technology assessment…
In addition to clinical data to demonstrate the safety and efficacy of a technology, life sciences small- and medium-sized enterprises (SMEs) require health economic data and analysis to demonstrate the cost-effectiveness of that technology for health systems, creating a comprehensive picture of how the technology is good value for money. Without this key component in an evidentiary…
Health Technology Innovation Platform HTIP is a public-private partnership between Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), provincial drug plans (AB, BC, ON) and the innovative pharmaceutical industry including, Boehringer Ingelheim, GlaxoSmithKline, Roche Canada, Takeda Canada, and Novartis Pharmaceuticals Canada Inc. The HTIP goals include…
The goal of the Alberta Secondary Use Data Access (SUDA) initiative is to accelerate health research, support innovation, and strengthen the health system through insights from analysis of health data. The IHE is serving as a partner to the Government of Alberta (GOA) to strengthen analytic capacity and foster collaboration between the GOA, industry, and other contributors. The…
This clinical practice guideline and background document were produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use…
This clinical practice guideline was produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use of public funds. This project…
This background document outlines the methods used to develop the Criteria for the Clinical Use of Immune Globulin, which was produced as part of the Prairie Collaborative Immune Globulin Utilization Management Framework project. The Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project was initiated to establish criteria for IG therapy as a means…
Community Voices: Diabetes in Indigenous Populations is a video project that aims to highlight Indigenous perspectives on health, and promote shared learning for a variety of stakeholders within the context of health, well-being, and health care in Canada. New videos from the series will be added regularly, and will highlight voices from Indigenous communities describing current…
3 June 2018 Vancouver, British Columbia On June 3rd, as part of the 2018 Health Technology Assessment International (HTAi) Annual Conference in Vancouver, the Institute of Health Economics (IHE) led a panel presentation on facilitators, innovators, and innovations in chronic obstructive pulmonary disease (COPD) care in Canada. The panel, Facilitating Adoption of Innovative…
PDF of a PowerPoint Presentation by George Habib, President and CEO, Lung Association of Ontario.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
PDF of a PowerPoint presentation by Shelley Valaire, Senior Provincial Director, Respiratory Health Strategic Clinical Network (RHSCN), Alberta.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
PDF of PowerPoint presentation by Tatiana Makhinova, Assistant Professor, Faculty of Pharmacy and Pharmaceutical Services, University of Alberta.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
| Jasmine Brown, Roger Bland, Egon Jonsson, Andrew Greenshaw
Objective: Fetal alcohol spectrum disorder (FASD) is a medical term used to describe a range of mental and physical disabilities caused by maternal alcohol consumption. The role of alcohol as a teratogen and its effects on the cellular growth of the embryo and the fetus were not determined on scientific grounds until the late 1960s. However, the link between alcohol use during…
| Jasmine Brown, Roger Bland, Egon Jonsson, Andrew Greenshaw
Objective: Fetal Alcohol Spectrum Disorder (FASD) is a preventable disorder caused by maternal alcohol consumption and marked by a range of physical and mental disabilities. Although recognized by the scientific and medical community as a clinical disorder, no internationally standardized diagnostic tool yet exists for FASD. Methods and Results: This review seeks to analyse the…
| Charles Yan, Yufei Zheng, Michael D. Hill, Balraj Mann, Thomas Jeerakathil, Noreen Kamal, Shy Amlani, Anderson Chuck
Abstract: We present a conceptual approach to determine the optimal solution to delivering a health technology, consistent with the objective of maximizing patient outcomes subject to resources available to a publicly funded health system. The article addresses two key policy questions: 1) adding system values through appropriate planning of health services delivery and 2) considering…
This brief outlines some perspectives from the Institute of Health Economics (IHE) based on what we have heard from government, public agencies, and industry, and seeks to summarize the key areas where further clarification and deliberation could be helpful.
As the Federal Government contemplates introducing an element of value-based pricing to the pharmaceutical industry regulatory framework, this report provides an overview of key theoretical and empirical material, to support informed engagement by all stakeholders in this important debate.
Program
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum – Final ProgramDownload Final Program
Selected References
Dr. Holroyd's Selected References – Low Value Care / Cognitive BiasesDownload Selected References
Thursday, 22 February 2018Edmonton, Alberta 13:00 – 13:15 Welcome from the IHE Dr. Chris McCabeCEO, Institute of Health Economicshttps://vimeo.com/album/5021382/video/258736790 Greetings from the Province of Alberta Mr. Justin RiemerADM, Innovation & Strategic Operations, Alberta Healthhttps://vimeo.com/album/5021382/video/257997522 13:15 – 14:35 Where Does the…
Speaker Biograpies Keynote Speakers Dr. Brian O’Rourke Dr. Brian O’Rourke is the President and Chief Executive Officer of CADTH. He joined CADTH in January of 2009 following a distinguished career as a Pharmacist and Health Service Executive with the Canadian military. With over 30 years of experience in health care, Brian actively positions CADTH as the leading source…
22 February 2018 Edmonton, Alberta On February 22nd, 2018 the Institute Health Economics (IHE), the Canadian Agency for Drugs & Technologies in Health (CADTH), and Alberta Health presented a forum: Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making. The purpose of this event was to provide a platform for shared learning and to showcase CADTH and Alberta…
PDF of a PowerPoint presentation by Dr. Brian O’Rourke, CEO, Canadian Agency for Drugs and Technology in Health.
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum
PDF of a PowerPoint presentation by Dr. Sean Tunis, President, Health Technology Assessment International; Founder and CEO, Centre for Medical Technology Policy.
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum
| Rodger Craig, Carmen Moga, Bing Guo, Dagmara Chojecki
The Institute of Health Economics (IHE) was commissioned by the Canadian Cardiovascular Society to provide a rapid update of the literature, to compare the impacts of public reporting and external benchmarking on selected outcomes, and to evaluate and describe the applicability of this body of research to non- competitive health systems, emphasizing perspectives and considerations…
Objective: The aim of this study was to analyze the health care costs and savings associated with quality improvement (QI) interventions initiated and implemented utilizing the National Surgical Quality Improvement Program (NSQIP). Background: Five acute care facilities of Alberta Health Services (AHS) adopted NSQIP in 2015 for a pilot project. Methods: The cost-savings of NSQIP…
To learn more about the Alberta Real World Evidence (RWE) Consortium, please visit www.AlbertaRWE.ca! Evidence that captures the observed impact of a process or technology on health outcomes and resource utilization outside of controlled clinical trials (real-world evidence or RWE) is highly valuable to technology developers, manufacturers, regulators, payers, clinicians, and…
This report provides a summary of the proceedings from the IHE roundtable on diabetes care and management in Indigenous populations in Canada, held on November 1, 2017. The roundtable aimed to: discuss and share learnings and promising practices from successful community-led diabetes programs, highlighting approaches to effectively engage communities to co-develop prevention and…
Primary Care Low Back Exam factsheet - 2006.
Extracted from the Chronic Pain Management Binder November 2005.
Link to Alberta Ambassador Guideline Adaptation Program
This consensus development conference was commissioned by the Government of Alberta to improve the transition of its system of care for people with severe and persistent mental illness (SPMI) toward the community. The system, previously hospital- and institution-centred, is moving towards becoming a community-centred, patient- and family-led one. The development and deployment…
À titre de président du jury, le Dr Alain Lesage, M.D., FRCPC, M.Phil., DFAPA, professeur au département de psychiatrie de l'Université de Montréal et clinicien à l’Institut universitaire en santé mentale de Montréal, Québec, a dirigé un comité spécial dont le mandat était d'élaborer…
Clinical Resources | Patient Resources Clinical Practice Guideline Primary Care Management of Headache in Adults (2nd edition September 2016) Guideline Documents including Full Guideline hosted by Towards Optimized Practice (TOP) Albertahttps://actt.albertadoctors.org/CPGs/Pages/Headache.aspx Supporting Documents and Process Description Background Document, 2nd Edition.Download…
Clinical Resources | Patient Resources Clinical Practice Guideline Evidence-Informed Primary Care Management of Low Back Pain(3rd edition, December 2015; minor revision July 2017) Guideline Documents including Full Guideline hosted by Towards Optimized Practice (TOP) Albertahttps://actt.albertadoctors.org/CPGs/Pages/Low-Back-Pain.aspx Supporting Documents and Process Description…
| Caroline Sheppard, Erica Lester, Anderson Chuck, David Kim, Shahzeer Karmali, Christopher Gara, Daniel Birch
INTRODUCTION: The objective of this study was to determine the short-term cost impact thatmedical tourism for bariatric surgery has on a public healthcare system. Due to long wait times for bariatric surgery services, Canadians are venturing to private clinics in other provinces/countries. Postoperative care in this population not only burdens the provincial health system…
Health Economics Unit Health economics is a form of economics-based research that analyzes efficiency, effectiveness, value, and behaviour in the production and consumption of health and health care. Health Economic Services The IHE provides a wide range of economic analyses to inform effective allocation of health resources, including: Economic analyses: cost-effectiveness, cost-utility,…
2024 | 2023 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 Roundtables, Workshops, and Conferences are designed and intended to encourage collaboration and facilitate discussion among industry, academic, and government stakeholders. Various IHE events have also been produced in partnership with other organizations, and have seen…
In December 2008, the IHE launched a series of semi-annual innovation forums whose goal is to bring together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system, not just in Alberta, but to all of Canada and the international community, as well. Details of each session are available by selecting the event link below.…
Knowledge Transfer & Dissemination Knowledge transfer and dissemination is an integral part of the IHE’s activities. As a neutral convenor for health policy dialogue and evidence development and dissemination, the IHE has a well-established role in facilitating and supporting the translation of knowledge into practice. Included in the IHE’s knowledge transfer portfolio are numerous…
Health Technology Assessment and Evidence Reviews Health system decision-makers are frequently confronted with decisions about introducing innovative drugs, medical devices, surgical procedures, and processes of care, as well as optimizing the current delivery of care. These technologies and processes are complex, and assessing their value to the health system requires scientific…
Chair Mr. Robert Seidel, KC, Canada Managing Partner, DLA Piper Government and Public Authorities Mr. Andre Tremblay, Deputy Minister, Health Mr. David James, Deputy Minister, Alberta Technology and Innovation Mr. Tim Murphy, Vice President of Health at Alberta Innovates, Alberta Innovates Dr. Peter Jamieson, Interim Vice-President and Chief Medical Officer, Alberta Health Services…
The IHE is frequently requested to be a partner on academic grant applications and policy initiatives with other organizations. In particular we are often the economic analysis partner or knowledge transfer partner for other organizations. Academic University of Alberta http://www.ualberta.ca/ The U of A is a leader in research. Our campuses attract professors with international…
The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
In November 2014, the Institute of Health Economics partnered with Eli Lilly Canada Inc. and the Canadian Institutes of Health Research’s Institute for Health Services and Policy Research to hold a roundtable to discuss the federal role in healthcare innovation. The roundtable aimed to examine the existing state of healthcare innovation, its strengths and weaknesses (or gaps),…
Speaker Biographies Keynote Speakers Dr. Andreas LaupacisChair, Health Quality Ontario Dr. Laupacis is a general internist and the Executive Director of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is a Professor at the University of Toronto in both the Department of Medicine and the Institute of Health Policy, Management and Evaluation. Dr. Laupacis…
27 November 2014Edmonton, Alberta Welcome and Greetings from the Minister of Health WelcomeDr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://vimeo.com/channels/907291/113749308 Greetings from the ProvinceGlenn Monteith, Chief Delivery Officer, Alberta Healthhttp://vimeo.com/channels/907291/113749310 Keynote presentations Health System Standards: From Good Intent to…
27 November 2014 Edmonton, Alberta Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XII – Health System Standards: From Good Intent to Real World…
Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
Upcoming Events Information on upcoming events hosted by the Institute of Health Economics (IHE) as well as upcoming events hosted by national and international health economics organizations and associations. The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose,…
Creating Value Through Collaboration The Institute of Health Economics (IHE) is an independent, not-for-profit organization with key competencies in health economics, health technology assessment, and knowledge transfer/exchange. Our mission is to consistently provide relevant, timely and impactful evidence that supports informed health system policy and investment decisions…
Our History The Institute of Health Economics (IHE), formerly the Institute of Pharmaco-Economics, was founded in 1995 on the belief that the best solutions to healthcare problems are the result of a collaborative approach, with all stakeholders at the table sharing insights and information. First led by the Rt. Hon. Don Mazankowski (Board Chair) and Dr. Devidas Menon (CEO), the…
Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference 23 November 2014 Edmonton, Alberta This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the…
PDF of a PowerPoint Presentation by Dr. Ken Butcher, WMC Health Sciences Centre, University of Alberta. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference In this 45 minute presentation, Dr. Butcher reviewed how to diagnose stroke and discussed the burden of Cardioembolic and Cryptogenic Stroke. He talked about the recent…
PDF of a PowerPoint Presentation by Dr. Thomas Jeerakathil, Associate Professor, University of Alberta; Co-physician lead, ASPIRE TIA Triaging Project, Northern Stroke Lead CV/S SCN. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference This presentation looked at the diagnosis of likely TIA syndromes and how to identify and…
PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…
This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the continuously advancing field of stroke prevention and care, with a particular focus on the role of primary care. The forum was…
PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…
17 November 2014 Ottawa, Ontario The federal Ministry of Health (Health Canada) announced the creation of the Advisory Panel on Healthcare Innovation on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s directive is to determine what approaches hold the greatest potential for Canadians and to create…
Monday, 17 November 2014 Ottawa, Ontario Opening and Opening Remarks Moderator: Mr. John Sproule, IHE Ms. Lauren Fisher, Eli Lilly Canada Inc. Mr. Glenn Brimacombe, Canadian Psyciatric Association Roundtable Discussion: What can the federal government do to promote and support innovation in the healthcare system? Overview of current state of healthcare innovation from a Federal…
Summary Report
Health Innovation in Canada: Federal Role Roundtable: Summary ReportDownload Report
Background Document
Health Innovation in Canada: Federal Role Roundtable – BackgrounderDownload Background Document
The purpose of this roundtable was to gather a small, select group of thought leaders to engage in informed discourse, which was summarized in a report submitted to the new federal Healthcare Innovation Advisory Panel. This roundtable, created in response to the Federal Healthcare Innovation Advisory Panel’s call for stakeholder input, was an exciting opportunity to…
Objectives: To estimate the annual health services utilization (HSU) cost per person with FASD by sex and age; the lifetime HSU cost per person with FASD by sex, and the annual HSU cost of FASD for Alberta by sex.
| Victoria Ung, Thanh Nguyen, Karen Wong, Karen Kroeker, Thomas Lee, Haili Wang, Arto Ohinmaa, Philip Jacobs, Richard Fedorak
BACKGROUND & AIMS: Infliximab is effective for induction and maintenance of response in patients with moderate to moderately severe ulcerative colitis. Previous cost analyses of infliximab treatment for ulcerative colitis used models of colectomy vs infliximab and response rates derived from early clinical trials. In real life, therapeutic options are more complex; patients…
Speakers | Jury | Scientific Committee | Planning Committee Scientific Chair Roger Bland, CM, MB, ChB, FRCPC, FRCPsych Chair, Scientific Committee; Professor Emeritus, Department of Psychiatry, University of Alberta, Edmonton, Alberta Speakers Carol Adair, MSc, PhD Researcher, Psychiatric Epidemiologist and Associate Professor, Departments of Psychiatry and of Community…
Program Consensus Development Conference on Improving Mental Health Transitions 2014 - Final ProgramDownload Program Consensus Statement Consensus Statement on Improving Mental Health Transitions 2014Download Consensus Statement Déclaration de consensus sur l'amélioration des transitions en santé mentaleTélécharger la déclaration de consensus Media Release 6 November 2014 – Consensus…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
Tues 4 Nov 2014 | Wed 5 Nov 2014 | Thu 6 Nov 2014 Improving Mental Health Transitions 2014 - Final Program Tuesday, 4 November 2014 08:00 – 08:45 Opening RemarksRoger Bland, CM, MB, ChB, FRCPC, FRCPsychhttp://vimeo.com/channels/839914/112193615 GreetingsCouncillor Scott McKeenhttp://vimeo.com/112193618 Opening Prayer from ElderGloria Lairdhttp://vimeo.com/112193614 Improving Mental…
The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS) hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 - 6, 2014.
PDF of a PowerPoint presentation by Dr. Philippa Garety, MA, MPhil, MA (Ed), PhD, FBPsS.
Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Roger Bland, CM, MB, ChB, FRCPC, FRCPsych.
Consensus Development Conference on Improving Mental Health Transitions
2 November 2014 Toronto, Ontario In April 2014, we held the first roundtable discussion on the current and future role of real world evidence (RWE) in Canada, bringing together multiple stakeholders from across Canada and internationally. Workshop participants felt there was much more to explore in future discussion and a specific need was identified to focus part of future conversations…
Biographies Chris Henshall Health Economics Research Group (HERG), Brunel University Dr. Chris Henshall is an Honorary Professor at HERG and an independent consultant on health, research and innovation policy. Chris has held various academic and senior management positions in the health research system and the higher education system in the UK. He is an Associate Professor in the…
Sunday, 2 November 2014 Toronto, Ontario Opening and Opening Remarks John Sproule, IHE Lisa Marsden, VP of Market Access & Government Relations at AstraZeneca Canada Vasanthi Srinivasan, Executive Director, Ontario SPOR DSU PART I: Fit for purpose: When and where is real-world evidence most useful? Speaker: Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's…
Roundtable Final Report
Roundtable on Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report – September 2014Download Roundtable Final Report
Program
Real World Evidence: Priority Setting for Action – How to best use health system data to improve health?Download Program
Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support Unit (Ontario) and AstraZeneca Canada. It was held in conjunction with the annual Canadian Association for Population Therapeutics (CAPT).…
Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support…
PDF of a PowerPoint presentation by Dr. Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital.
Real World Evidence: Priority Setting for Action Roundtable
PDF of a PowerPoint presentation by Mr. Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan.
Real World Evidence: Priority Setting for Action Roundtable
| Don Husereau, Anthony Culyer, Peter Neumann, Philip Jacobs
Abstract: Canadian and US health systems have often been characterized as having vastly different approaches to the financing and delivery of healthcare, with Canada portrayed as more reliant on rationing based on costs. In this article, we examine the similarities and differences between the two countries, the evolution and current role of health economic evaluation, and…
Published quarterly by the KRP Tax Group, our newsletter provides up-to-date information regarding the latest tax rules and accounting principles. To subscribe to our electronic newsletter, please fill out the form below:
Privacy Statement The Institute of Health Economics values your privacy. This Privacy Statement of the Institute of Health Economics (IHE), 1200 – 10405 Jasper Avenue NW, Edmonton, Alberta T5J 3N4 ("IHE" "we" "us" or "our") outlines how your personally identifiable information and other data relating to you (your "personal data") will be collected, used, and shared in connection…
Media Inquiries John Sproule, Senior Policy Director Email: [email protected] Phone: 780-862-1905. General Inquiries The Institute of Health Economics welcomes your inquiries. If you wish to receive more information about any of our products or services, please either use the form below or contact us at the address listed below. Institute of Health Economics 1200, 10405 Jasper…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the clinical effectiveness and safety of hysteroscopic tubal sterilization, and the value for money associated with adopting hysteroscopic tubal sterilization in Alberta. Section Authors: Section One – Background and Context: Carmen…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose…
| Arto Ohinmaa, Thanh Nguyen, Cheryl Barnabe, Liam Martin, Anthony Russell, Susan G Barr, Walter Maksymowych
OBJECTIVE: To provide Canadian estimates of health care utilization costs associated withrheumatoid arthritis (RA)-related and non-RA-related care within 4 treatment strategies and in different physical functioning categories.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…
| Cheryl Barnabe, Thanh Nguyen, Arto Ohinmaa, Joanne Homik, Susan G Barr, Liam Martin, Walter Maksymowych
OBJECTIVE: Sustained remission in rheumatoid arthritis (RA) results in healthcare utilizationcost savings. We evaluated the variation in estimates of savings when different definitions ofremission [2011 American College of Rheumatology/European League Against Rheumatism Boolean Definition, Simplified Disease Activity Index (SDAI) ≤ 3.3, Clinical Disease Activity Index…
| Carolyn Dewa, Desmond Loong, Sarah Bonato, Thanh Nguyen, Philip Jacobs
BACKGROUND: Interest in the well-being of physicians has increased because of their contributions to the healthcare system quality. There is growing recognition that physicians are exposed to workplace factors that increase the risk of work stress. Long-term exposure to high work stress can result in burnout. Reports from around the world suggest that about one-third to…
Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…
| Don Husereau, Philip Jacobs, Braden Manns, Ties Hoomans, Deborah Marshall, Robyn Tamblyn
This discussion paper has been produced in response to a request from CIHR Institute of Health Services and Policy Research (CIHR IHSPR). The discussion paper will provide guidance to those tasked with conducting an economic evaluation of complex health system interventions. The guidance will be an elaboration of existing National guidelines for economic evaluation, and serve as…
Antibiotic-Resistant Organisms (AROs) are a serious health problem, though they are more prevalent in some settings than others. We were asked to make findings and develop recommendations on how to address surveillance of and screening for AROs in acute care hospitals. This consensus statement addresses these requests. However, confining the discussion and recommendations to hospitals…
PDF of a PowerPoint presentation by Dr. Elizabeth Bryce, BSc, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Daniel Gregson, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Lindsay Nicolle, BSc, BSc (med), MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Anthony Harris, MD, MPH.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPath.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Ms. Kim Neudorf.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Yves Longtin, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Trish Perl, MD, MSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Eli Perencevich, MD, MS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Mark Loeb, BSc, MSc, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Serge Desnoyers, PhD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
18 – 20 June 2014 Calgary, Alberta The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 – 20, 2014, was the first event of its kind to look at issues in the field of AROs. Download Consensus Statement The Consensus Conference model is an exciting format, geared to creating…
Speakers | Jury | Scientific Committee | Organizing Committee Speakers Elizabeth Bryce, BSc, MD, FRCPCRegional Medical Director for Infection Control, Vancouver Coastal Health; Clinical Professor, University of British Columbia (UBC) Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPathProfessor, University College and London School…
Weds 18 June 2014 | Thurs 19 June 2014 | Fri 20 June 2014 Surveillance and Screening for Antimicrobial Resistant Organisms (AROs) 2014 - Final Program Wednesday, 18 June 2014 08:00 – 08:15 Opening RemarksDr. John Conly and Dr. James Talbothttp://vimeo.com/channels/910470/99417520 08:15 – 09:45 QUESTION 1: Overview a) What are AROs? What is their incidence…
Program Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) 2014 – Final ProgramDownload Program Consensus Statement Consensus Statement on Surveillance and Screening of AROs (Antimicrobial-Resistant Organisms)Download Consensus Statement Remarks from Jury Chair Remarks from the jury chair, Dr. Tom Marrie, Dean of…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
PDF of a PowerPoint presentation by Dr. Pilar Ramon-Pardo, MD, PhD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Howard Njoo, MD, MHSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Julian Davies, BSc, PhD, FRS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Scott McEwen, DVM, DVSc, Dip ACVP.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Joel Kettner, MD, MSc, FRCSC, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Andrew Simor, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Robert Weinstein, MD.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. James Talbot, PhD, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. David Patrick, MD, FRCPC, MHSc.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Michael Edmond, MD, MPH, MPA.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Henri Verbrugh, MD, PhD, FIDSA.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Allison McGeer, MD, FRCPC.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Susan Huang, MD, MPH.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. John Jernigan, MD, MS.
Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 - 20, 2014, was the first event of its kind to look at issues in the field of AROs.
| Carolyn Dewa, Philip Jacobs, Thanh Nguyen, Desmond Loong
BACKGROUND: Interest in the impact of burnout on physicians has been growing because of the possible burden this may have on health care systems. The objective of this study is toestimate the cost of burnout on early retirement and reduction in clinical hours of practicingphysicians in Canada.
The objective of this paper is to estimate the additional costs to the criminal justice system associated with people with mental illness who go through the system. The focus of the report is on costs in Alberta.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…
Thursday, 29 May 2014 Edmonton, Alberta The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Key Symposium Documents Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program Rheumatoid Arthritis…
Speaker Biographies Dianne Mosher, MD Dr. Dianne Mosher is currently Professor of Medicine and the Chief of the Division of Rheumatology at the University of Calgary. She has practiced Rheumatology for the past twenty years having graduated from Dalhousie Medical School in 1983 where she also completed her Internal Medicine and Rheumatology residency training. Dr. Mosher is a past…
Thursday, 29 May 2014 Edmonton, Alberta Moderator Dianne Mosher, University of Calgary 09:00 – 09:15 Welcome and Opening Remarks Michele Evans, Executive Director, Pharmaceutical Funding and Guidance, Government of Albertahttp://vimeo.com/album/3477664/video/97379108 09:15 – 09:30 Biologic and Biosimilar Therapies - The Changing Landscape of the Management of Rheumatoid…
Symposium Program
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program
White Paper
Rheumatoid Arthritis in a Policy Perspective: A registry for research and better treatment of Albertans – White PaperDownload White Paper
PDF of PowerPoint Presentation by Dr. Dianne Mosher, Chief, Division of Rheumatology, Department of Medicine, University of Calgary.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Liam Martin, Professor, University of Calgary.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts (ACE).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Micheal Guirguis, Drug Stewardship Pharmacist, Alberta Health Services (AHS).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Ms. Suzanne Lepage, Private Health Plan Strategist.
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Agnes Klein, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada, Health Canada. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium Note: Slide 16 of this presentation contains an error…
PDF of a PowerPoint Presentation by Dr. Chander Sehgal, Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
Speaker Biographies Keynote Speakers Dr. Sube Banerjee MB BS, MSc, MBA, MD, FRC Psych, MBEProfessor & Associate Dean, Brighton and Sussex Medical School Sube Banerjee is Professor of Dementia and Associate Dean for Strategy at Brighton and Sussex Medical School, directing its Centre for Dementia Studies. Clinically he works as an old age psychiatrist in Sussex. He was the Department…
27 May 2014Edmonton, Alberta Welcome and Greetings from the Minister of Health Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/97426151 Keynote presentations Quality of life and quality of care in dementiaDr. Sube Banerjee, Brighton and Sussex Medical SchoolDownload Presentation http://vimeo.com/channels/907291/97466183 Coordinating Care…
27 May 2014 Edmonton, Alberta Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care – FINAL PROGRAMDownload…
Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Sube Banerjee, Brighton and Sussex Medical School.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. Duncan Robertson, Seniors Health Strategic Clinical Network, Alberta Health Services.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. Carole Estabrooks, University of Alberta.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. David C. Grabowski, Harvard Medical School.
IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
This informative PowerPoint is publicly available for use as an introductory resource for justice professionals who are seeking an educational tool to assist in group presentations/training regarding involvement of those with Fetal Alcohol Spectrum Disorder (FASD) in the criminal justice system.
Le PowerPoint informative est publiquement disponible pour une utilisation en tant que ressource d'introduction pour les professionnels de la justice qui cherchent un outil pédagogique pour aider à des présentations de groupe / formation concernant la participation de ceux qui ont des troubles causés par l'alcoolisation fœtale (ETCAF ) dans le…
Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors. OBJECTIVE: The aim of this study was to estimate the cost-savings attainable if all patients aged ≥65 years in Alberta, Canada, currently on…
OBJECTIVES: The objective of this study was to explore the degree to which databases otherthan MEDLINE contribute studies relevant for inclusion in rapid health technology assessments (HTA).
This report has been produced in response to a request from Alberta Health (AH). The objective was to perform a review of practices of engaging committees composed of lay people or members of the general public at international, national, provincial, and regional levels. The review attempts to address the following questions: What scientific evidence is available about committees…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
| Lianne Barnieh, Braden Manns, Anthony Harris, Marja Blom, Cam Donaldson, Scott Klarenbach, Don Husereau, Diane Lorenzetti, Fiona Clement
BACKGROUND: The use of a restrictive formulary, with placement determined through a drug-reimbursement decision-making process, is one approach to managing drug expenditures.
IHE In Your Pocket 2014 – a handbook of health economic statistics includes the most currently available data, presented in separate sections on the economic burden of illness, health care resources, health behaviours, health status and demographics, and health system performance. IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #24. This report has been produced in response to a request from Alberta Health and Wellness for an update on the use of vagus nerve stimulation (VNS) for refractory epilepsy. The intent was to inform health policy makers, medical practitioners, and the public on the current status of the use of VNS for refractory…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #23. This report is a systematic review and critical appraisal of the literature on the use of formal outpatient diabetes education as a therapeutic tool for self-management in adult patients with type 2 diatetes. It has been prepared to provide information to the Capital Health Authority in Alberta, Canada and…